Lorraine Bertelle
Family · Brooklyn, NYNPI 1932356581
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 275 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by AbbVie at 28.3% of the total. Among family clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 275 payments — averaging $33.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Novo Nordisk$918
- Merck$720
- Boehringer Ingelheim$522
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$436
- E.r. Squibb & Sons, L.L.C.$355
- plus $4K from 24 others
What the payments were for
- Food & beverage$9,089100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 69 | $2,572 |
| Novo Nordisk | 22 | $918 |
| Merck | 25 | $720 |
| Boehringer Ingelheim | 12 | $522 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 26 | $436 |
| E.r. Squibb & Sons, L.L.C. | 12 | $355 |
| Esperion Therapeutics, Inc. | 10 | $311 |
| GSK | 9 | $308 |
| Biohaven Pharmaceutical Holding Company Ltd. | 13 | $292 |
| AstraZeneca | 9 | $279 |
| Teva Pharmaceuticals USA, Inc. | 4 | $268 |
| Pfizer | 7 | $257 |
| Axsome Therapeutics, Inc. | 2 | $241 |
| Otsuka America Pharmaceutical, Inc. | 2 | $232 |
| Lilly USA, LLC | 12 | $231 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $162 |
| Amgen | 7 | $161 |
| Madrigal Pharmaceuticals | 1 | $143 |
| Biohaven Pharmaceuticals, Inc. | 4 | $92 |
| Shionogi Inc | 3 | $87 |
| Amarin Pharma, Inc. | 4 | $83 |
| Exact Sciences | 3 | $77 |
| Ironwood Pharmaceuticals, Inc | 3 | $71 |
| Johnson & Johnson | 3 | $65 |
| Paratek Pharmaceuticals, Inc. | 3 | $61 |
| Kowa Pharmaceuticals America, Inc. | 3 | $49 |
| Nevro Corp. | 1 | $33 |
| Vifor Pharma, Inc. | 1 | $24 |
| Novartis | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,089 in reported general payments places this provider in the 95th percentile of 8,883 family providers in New York.
Other family in Brooklyn
- Seida VelijaBrooklyn$62K
- Ofiong OkonBrooklyn$44K
- Irina FainbergBrooklyn$23K
- Susan WeissBrooklyn$22K
- Razan AlawadhiBrooklyn$21K
- Christina LaoBrooklyn$20K
- Christina NalboneNew York$197K
- Casey GrilloNew York$191K
- Suzanne WilsonIthaca$179K
- Jonathan LesuerSyracuse$172K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.